简体中文 | 繁體中文 | English

Quintiles 01

Quintiles Extends Data Management Expertise, Capabilities to China

2010-08-10 11:58
  • zh_cn
  • zh_hant
  • en

Expansion Bolsters Quintiles’ Leadership Position in China and Asia-Pacific

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the expansion of its data management services into Shanghai, China, strengthening the company’s capability to serve customers in that country and the Asia-Pacific region.

“China is an integral component of the New Health landscape, quickly becoming one of the key markets for biopharmaceutical development and innovation,” said Ling Zhen, General Manager, Quintiles China. “As a pioneer in the China clinical development industry, we have seen tremendous growth in demand for our services as biopharmaceutical customers look to enhance their operational efficiencies and position in this growing market.”

Lalit Pai, Head, Quintiles Global Data Management, said: “With regional data management operations in Japan, India and now China, Quintiles can continue to deliver operational efficiencies and cost-savings for our customers, while offering services in local time zones with local expertise. The Shanghai expansion will allow us to lead biometrics in China, serving local customers, as well as customers throughout Asia-Pacific.”

Quintiles’ dedicated team of data management professionals in Shanghai will work closely with the company’s biostatistics and medical writing teams in China to accommodate customer demand for increased efficiencies through integrated services.

Quintiles China includes offices in Beijing and Hong Kong, which opened in 1997, Shanghai, which opened in 1998, and a network of locally-based staff. With recently expanded anatomical pathology capabilities at its Beijing facility, Quintiles continues to strengthen its presence in China, offering the entire range of clinical services.

Quintiles, a pioneer in the Asia-Pacific clinical research industry, opened its first office in the region in 1993. Since that time, the company has grown to more than 20 offices in 14 countries throughout the region with its regional headquarters in Singapore.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

Contacts

Quintiles
Lindsay Singler, Media Relations, 919-998-7968, lindsay.singler@quintiles.com
Greg Connors, Investor Relations, 919-998-2000, invest@quintiles.com
www.quintiles.com